Yiqifumai injection and its main ingredients attenuate lipopolysaccharide-induced cerebrovascular hyperpermeability through a multi-pathway mode.,Microcirculation

当前位置： X-MOL 学术 › Microcirculation › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

Yiqifumai injection and its main ingredients attenuate lipopolysaccharide-induced cerebrovascular hyperpermeability through a multi-pathway mode.
Microcirculation ( IF 1.9 ) Pub Date : 2019-07-21 , DOI: 10.1111/micc.12553
Dan-Tong Li _{1,

2,

3,

4} , Kai Sun _{2,

3,

4,

5} , Ping Huang _{2,

3,

4,

5} , Chun-Shui Pan _{2,

3,

4,

5} , Li Yan _{2,

3,

4,

5} , Ayididaer Ayan _{2,

3,

4,

5,

6} , Yu-Ying Liu _{2,

3,

4,

5} , Jing-Yu Fan _{2,

3,

4,

5} , Wei-Gang Fang ₁ , Jing-Yan Han _{2,

3,

4,

5,

6}

Affiliation

Yiqifumai injection is a compound Chinese medicine used to treat microcirculatory disturbance‐related diseases clinically. Our previous study proved that Yiqifumai injection pretreatment inhibited lipopolysaccharide‐induced venular albumin leakage in rat mesentery. This study aimed to investigate whether Yiqifumai injection attenuated cerebral microvascular hyperpermeability and corresponding contribution of its main ingredients.

中文翻译：